A Remote Electrical Neuromodulation Device for Acute Migraine Treatment
A remote electrical neuromodulation (REN) device may offer a safe and effective non-pharmacologic alternative for acute migraine treatment.
All articles by Virginia Schad
Neurocardiac Injury by Strain Imaging in Patients With Subarachnoid Hemorrhage
Neurocardiac injury detected by strain imaging appears to be a marker for the extent of neurological insult, and is a new prognostic marker in patients with SAH.
Association Between Restless Legs Syndrome and Other Movement Disorders
Several reports describe a possible association between restless legs syndrome and Parkinson disease, as well as Tourette syndrome and restless legs syndrome.
Longitudinal Cerebrospinal Fluid Biomarker Trajectories in Alzheimer Disease
Total tau and phosphorylated tau follow a different pattern of change in Alzheimer disease.
Diffusion-Weighted Imaging: Recurrent Ischemic Stroke Risk After TIA
An acute diffusion-weighted imaging lesion may predict an increased long-term risk for recurrent ischemic stroke after transient ischemic attack or minor stroke.
Cyclic Vomiting Syndrome and Benign Paroxysmal Torticollis May Lead to Primary Headache
Cyclic vomiting syndrome (CVS) and benign paroxysmal torticollis (BPT) during infancy are associated with a high risk for developing headache later in life.
Erenumab Reduces Migraine Frequency in Chronic Migraine With Medication Overuse
In patients with chronic migraine (CM) and medication overuse, erenumab reduces migraine frequency.
Carotid Stenosis Common in Patients Presenting With Stroke, TIA
Careful multidisciplinary team discussion may avoid unnecessary intervention in patients with carotid stenosis presenting with stroke or transient ischemic attack.
Stroke Risk Reduced With Rivaroxaban in Embolic Stroke of Undetermined Source
Rivaroxaban was associated with a reduced recurrent stroke risk in patients with embolic stroke of undetermined source.
Tyrosine Kinase Inhibitor Reduces Inflammation, Alpha-Synuclein in PD
A single dose of nilotinib reduces inflammation and alpha-synuclein in patients with Parkinson’s disease.
Next post in Movement Disorders
